The 4 analysts offering 12-month price forecasts for NightHawk Biosciences Inc have a median target of 11.00, with a high estimate of 15.50 and a low estimate of 8.00. The median estimate represents a +395.50% increase from the last price of 2.22.
The current consensus among 4 polled investment analysts is to Buy stock in NightHawk Biosciences Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.34
Reporting Date Aug 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.